Retina

Francesco Bandello, MD, FEBO, discusses the Diabetic Eye Conditions Coalition and a five-point call to action

Risk factors vary in both short-term and long-term periods following Boston Type 1 keratoprosthesis surgery

The UK-based company will debut the tool, called Dr.Noon CVD, at two conferences in March

Professor Anat Loewenstein, MD, speaks about her presentation from the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting

The authors evaluated shallow irregular pigment epithelial detachment, subretinal hyperreflective material, subretinal fluid, intraretinal fluid and other baseline OCT biomarkers

Researchers screened for outcomes such as the presence of retinal diseases including age-related macular degeneration and retinal vein occlusion

The implant was tested in eyes of patients with bilateral age-related macular degeneration who underwent cataract surgery

Choroidal and retinal changes were examined with optical coherence tomography angiography

Previously, Susvimo was called the Port Delivery System with ranibizumab in the United States

OCU400 is the first gene therapy from the biotechnology company to move forward into Phase 3 with a broad retinitis pigmentosa (RP) indication

Pavblu and Skojoy, both from Amgen, are indicated for the treatment of neovascular age-related macular degeneration

The lead gene therapy candidate, AXV-101, is expected to enter clinical development in mid-2025

The gel addresses necrotic retinal cell death in dry age-related macular degeneration and geographic atrophy without requiring injections

The scientific outputs from MACUSTAR’s study could impact more than 200 million patients with AMD globally

Diana V. Do, MD, spoke on behalf of the HELIOS investigators at the Hawaiian Eye and Retina 2025 Meeting, in Kauai, HI

Ultrasounds reveal the distinct feature within the vitreous anterior, a promising diagnostic indicator for ocular pathologies

ARCATUS or ARVN001 was developed by Clearside Biomedical and commercialised in the Asia-Pacific region by Arctic Vision

Predictive software will use retinal imaging to identify patient risk for Alzheimer and other neurodegenerative diseases

The study findings suggest that patients should be educated about adherence to cold storage guidelines

The updated device is designed to meet market diagnostic needs, including within geographic atrophy research

The transferrin vectorised therapy is being investigated for use in patients with dry age-related macular degeneration and geographic atrophy

The commercialisation agreements for the biosimilar to aflibercept (Eylea) cover Israel, major parts of Europe and the Asia-Pacific Region

The study built on previous research indicating specific retinal variables can serve as disease-related biomarkers in neurodegenerative diseases

The authors investigated systemic adverse events associated with commercial mydriatics administered during retinopathy of prematurity (ROP) screening

ViGeneron, based in Munich, also received approval for dose escalation in the ongoing phase 1b clinical trial

Investigators reported that the trial demonstrated significant improvements in visual function and retinal structure for patients with optic neuritis

In October, Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for treatment of diabetic macular oedema

Patients with fibromyalgia experienced changes in the macular ganglion cell layer and retinal nerve fiber layer

The RESTORE Study is the follow-up study of the RESCUE and REVERSE studies of lenadogene nolparvovec to treat vision loss from LHON

Investigators emphasised the need for continued efforts to raise awareness and support patients in attending regular screening